BioSpace News Archive

Injectable Drug Delivery Market Size to Reach USD 83.38 Billion in 2030

Convenience and At-Home Accessibility Afforded by Injectable Pharmaceuticals are Key Factors Driving Industry Demand, Says Emergen Research

April 4, 2022
·
8 min read
Antibody-Drug Conjugates (ADCs) Market Growth – at a CAGR of 25.8% During Forecast Period 2020-2028

Increasing prevalence of various types of cancers across the globe, growing geriatric population, and rising investments in developing novel therapeutics are some key factors expected to drive global market growth.

April 4, 2022
·
5 min read
Business

Urovant Sciences Announces Appointment of Sef Kurstjens as Executive Vice President and Chief Medical Officer

Urovant Sciences, a wholly-owned subsidiary of Sumitovant Biopharma Ltd., today announced Sef Kurstjens, M.D., PhD., has been appointed Executive Vice President and Chief Medical Officer (CMO).

April 4, 2022
·
6 min read
Biotech Bay

Vivace Therapeutics to Present New Data from Preclinical Combination Studies of VT3989 and Osimertinib at American Association for Cancer Research (AACR) Annual Meeting 2022

Vivace Therapeutics, Inc., today announced that new preclinical data on the company’s transcriptional enhanced associate domain (TEAD) autopalmitoylation inhibitor, VT3989, will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2022.

April 4, 2022
·
2 min read
BioCapital

ACC.22: Medtronic renal denervation system demonstrates significant blood pressure reduction through three years

Medtronic plc which were presented at the American College of Cardiology’s 71st Annual Scientific Session late-breaking featured clinical research sessions.

April 4, 2022
·
6 min read
Drug Development

Bayer Presents New Subgroup Analyses for KERENDIA® (finerenone) for Chronic Kidney Disease Associated With Type 2 Diabetes With or Without History of Atherosclerotic Cardiovascular Disease

Bayer announced today late-breaking data from prespecified exploratory subgroup analyses of FIDELITY, a prespecified pooled analysis of the Phase III FIDELIO-DKD and FIGARO-DKD trials.

April 4, 2022
·
16 min read
BioCapital

BIO-LIBRA Initial Interim Analysis Results Demonstrate Higher Probability of Ventricular Tachyarrhythmias or Mortality in Men than Women

In conjunction with BIOTRONIK, Valentina Kutyifa, MD, PhD, presented the first interim analysis results from the BIO-LIBRA study in a poster contribution at the American College of Cardiology’s 71st Annual Scientific Session.

April 4, 2022
·
2 min read
Pharm Country

Pancreatic Cancer Cells Harness Normal Tissue Turnover to Build Protective Barriers

In the presence of pancreatic tumors, certain immune cells break down structural proteins into molecules that trigger the building of dense tissue, a known barrier to therapy, a new study finds.

April 4, 2022
·
4 min read
Approval by Regulatory Bodies for Orphan Drugs Market to Accelerate Treatment of Rare Diseases

Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and European Medicines Administration (EMA) have been offering the status of orphan drug designation (ODD) to new drugs and biologics.

April 4, 2022
·
3 min read
New Initiatives and Investments Arrive to Promote Medical Tourism

Promoting medical tourism plays a crucial part in improving economy of the country and the city.

April 4, 2022
·
2 min read